跳至主要内容
临床试验/NCT00232674
NCT00232674已完成4 期

The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT).

AstraZeneca2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 1999年7月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
AstraZeneca
入组人数
240
试验地点
2
主要终点
The primary variable in the study was change in lung density measured by Computed Tomography annually.

研究概览

简要总结

To assess the effect of up to 4 years treatment with budesonide on progression of emphysema in patients with Chronic Obstructive Lung Disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical Chronic Obstructive Pulmonary Disease diagnosis

排除标准

  • No exacerbation within the last 30 days
  • no long term use of oral corticosteroids

结局指标

主要结局

The primary variable in the study was change in lung density measured by Computed Tomography annually.

次要结局

  • Decline in lung Function (FEV1) and exacerbation rate were measured biannually and decline in diffusion capacity (TLCO) annually.

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

Efficacy Study of the Effect of Budesonide on... | 临床试验